New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:45 EDTGTHPGuided Therapeutics announces presentation of LuViva study
LuViva, a non-invasive device used to detect cervical disease instantly at the point of care, is a product of Guided Therapeutics. The LuViva Advanced Cervical Scan identified 100% of all cervical disease cases in a blinded clinical study presented at the International Federation for Cervical Pathology and Colposcopy meeting in London. LuViva also correctly identified 44% of women who had a previous abnormal Pap test and who were determined to be false positives as part of the study. According to the conclusions of the study, the high sensitivity, specificity and resulting high negative predictive value of LuViva imply that nearly half of the women currently undergoing colposcopy and biopsy could safely avoid those procedures, thereby improving clinic efficiency and resulting in significant savings to health care systems.
News For GTHP From The Last 14 Days
Check below for free stories on GTHP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for GTHP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use